Subscribe to RSS
DOI: 10.1055/s-0040-1717871
Diagnostic Leukapheresis for transcriptomic profiling of single CTCs: Characterization of inter CTC heterogeneity in terms of endocrine resistance
Introduction CTCs hold great promise with regard to prognosis, monitoring and treatment optimization of breast cancer patients. Single CTC transcriptomic profiling might help reveal valuable information concerning intra-patient heterogeneity relevant to therapeutic interventions. In this study, we combined Diagnostic Leukapheresis (DLA), microfluidic enrichment with the ParsortixTM system, micromanipulation with the CellCelectorTM and subsequent single cell multi-marker transcriptomic profiling.
Material and methods A PCR panel consisting of 30 different phenotypic and endocrine resistance markers was validated for single cell profiling by using different breast cancer cell lines. This panel was applied to characterize uncultured and cultured CTCs, which were enriched from a cryopreserved DLA product obtained from a patient suffering from metastatic breast cancer resistant to endocrine therapy.
Results Gene expression profiles of both CTC populations uncovered inter CTC heterogeneity for transcripts, which are associated with response or resistance to endocrine therapy (e.g., ESR1, HER2, FGFR1). Hierarchical clustering revealed CTC subpopulations with different expressions of transcripts regarding the CTCs’ differential phenotypes (EpCAM, CD44, CD24, MYC, MUC1) and of transcripts involved in endocrine signaling pathways (FOXO, PTEN). ER-positive CTCs exhibited significant higher expression of Cyclin D1, which might be relevant for CDK4/6 inhibitor therapies. Overall, gene expression profiles of uncultured and cultured CTCs resulted in a partly combined grouping.
Conclusion Multi-marker RNA profiling of enriched single uncultured CTCs and cultured CTCs form cryopreserved DLA samples may provide important insights into intra-patient heterogeneity relevant for targeted therapies and therapy resistance.
#
Interessenkonflikt
Es bestehen keine Interessenkonflikte.
Publication History
Article published online:
07 October 2020
© 2020. Thieme. All rights reserved.
Rüdigerstraße 14, 70469 Stuttgart, Germany